In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Theriva Biologics Inc (AMEX: TOVX) closed at $0.2 in the last session, down -4.78% from day before closing price of $0.21. In other words, the price has decreased by -$4.78 from its previous closing price. On the day, 1.83 million shares were traded. TOVX stock price reached its highest trading level at $0.2 during the session, while it also had its lowest trading level at $0.1887.
Ratios:
We take a closer look at TOVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.31.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 7030604 and an Enterprise Value of 1880709.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.56, which has changed by -0.8507463 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $1.75, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is -10.59%, while the 200-Day Moving Average is calculated to be -58.32%.
Shares Statistics:
According to the various share statistics, TOVX traded on average about 14.91M shares per day over the past 3-months and 2350320 shares per day over the past 10 days. A total of 35.69M shares are outstanding, with a floating share count of 34.88M. Insiders hold about 2.26% of the company’s shares, while institutions hold 1.22% stake in the company. Shares short for TOVX as of 1767139200 were 12169782 with a Short Ratio of 0.82, compared to 1764288000 on 2479067. Therefore, it implies a Short% of Shares Outstanding of 12169782 and a Short% of Float of 34.1.
Earnings Estimates
. The current rating of Theriva Biologics Inc (TOVX) reflects the combined expertise of 1 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$2.15 and -$2.15 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$0.75, with 1.0 analysts recommending between -$0.75 and -$0.75.
